{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:07:23Z","timestamp":1769116043019,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00125-018-4727-7","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T10:55:58Z","timestamp":1537354558000},"page":"2643-2653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study"],"prefix":"10.1007","volume":"61","author":[{"name":"for the SURDIAGENE Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Fraty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Velho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Gand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9deric","family":"Fumeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Sosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Mohammedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnabas","family":"Gellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Jean","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Montaigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Ducrocq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Marre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"4727_CR1","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) (1998) UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854\u2013865","journal-title":"Lancet"},{"key":"4727_CR2","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2337\/diacare.26.8.2433","volume":"26","author":"DS Bell","year":"2003","unstructured":"Bell DS (2003) Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26:2433\u20132441","journal-title":"Diabetes Care"},{"key":"4727_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2105\/AJPH.84.1.20","volume":"84","author":"L Bonneux","year":"1994","unstructured":"Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ (1994) Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 84:20\u201328","journal-title":"Am J Public Health"},{"key":"4727_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams Jr","year":"2005","unstructured":"Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209\u2013216","journal-title":"Am Heart J"},{"key":"4727_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.diabres.2014.03.015","volume":"104","author":"FJ Carrasco-Sanchez","year":"2014","unstructured":"Carrasco-Sanchez FJ, Gomez-Huelgas R, Formiga F et al (2014) Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: findings from the RICA registry. Diabetes Res Clin Pract 104:410\u2013419","journal-title":"Diabetes Res Clin Pract"},{"key":"4727_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0735-1097(98)00634-2","volume":"33","author":"F Zannad","year":"1999","unstructured":"Zannad F, Briancon S, Juilliere Y et al (1999) Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. Epidemiologie de l\u02bcInsuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 33:734\u2013742","journal-title":"J Am Coll Cardiol"},{"key":"4727_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/dci17-0052","volume":"41","author":"M Packer","year":"2018","unstructured":"Packer M (2018) Heart failure: the most important preventable and treatable cardiovascular complication of type 2 diabetes. Diabetes Care 41:11\u201313","journal-title":"Diabetes Care"},{"key":"4727_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2337\/dc17-0544","volume":"41","author":"JC Berge Van den","year":"2018","unstructured":"Van den Berge JC, Constantinescu AA, Booiten HJ et al (2018) Short term and long-term prognosis of patients with acute heart failure with and without diabetes: changes over the last decades. Diabetes Care 41:143\u2013149","journal-title":"Diabetes Care"},{"key":"4727_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jemt.10048","volume":"57","author":"N Minamino","year":"2002","unstructured":"Minamino N, Kikumoto K, Isumi Y (2002) Regulation of adrenomedullin expression and release. Microsc Res Tech 57:28\u201339","journal-title":"Microsc Res Tech"},{"key":"4727_CR10","doi-asserted-by":"publisher","first-page":"17787","DOI":"10.1074\/jbc.273.28.17787","volume":"273","author":"S Cormier-Regard","year":"1998","unstructured":"Cormier-Regard S, Nguyen SV, Claycomb WC (1998) Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 273:17787\u201317792","journal-title":"J Biol Chem"},{"key":"4727_CR11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/01.CIR.95.5.1214","volume":"95","author":"M Nakamura","year":"1997","unstructured":"Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K (1997) Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 95:1214\u20131221","journal-title":"Circulation"},{"key":"4727_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","volume":"51","author":"NG Morgenthaler","year":"2005","unstructured":"Morgenthaler NG, Struck J, Alonso C, Bergmann A (2005) Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51:1823\u20131829","journal-title":"Clin Chem"},{"key":"4727_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/eurjhf\/hfp004","volume":"11","author":"C Adlbrecht","year":"2009","unstructured":"Adlbrecht C, Hulsmann M, Strunk G et al (2009) Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients. Eur J Heart Fail 11:361\u2013366","journal-title":"Eur J Heart Fail"},{"key":"4727_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jacc.2010.01.060","volume":"56","author":"OS Dhillon","year":"2010","unstructured":"Dhillon OS, Khan SQ, Narayan HK et al (2010) Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study. J Am Coll Cardiol 56:125\u2013133","journal-title":"J Am Coll Cardiol"},{"key":"4727_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.2009.943","volume":"302","author":"O Melander","year":"2009","unstructured":"Melander O, Newton-Cheh C, Almgren P et al (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49\u201357","journal-title":"JAMA"},{"key":"4727_CR16","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.2337\/db14-1852","volume":"64","author":"G Velho","year":"2015","unstructured":"Velho G, Ragot S, Mohammedi K et al (2015) Plasma adrenomedullin and allelic variation in the ADM gene and kidney disease in people with type 2 diabetes. Diabetes 64:3262\u20133272","journal-title":"Diabetes"},{"key":"4727_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/CIRCHEARTFAILURE.114.001185","volume":"7","author":"FP Brouwers","year":"2014","unstructured":"Brouwers FP, van Gilst WH, Damman K et al (2014) Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort. Circ Heart Fail 7:723\u2013731","journal-title":"Circ Heart Fail"},{"key":"4727_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.peptides.2007.12.006","volume":"29","author":"H Nishida","year":"2008","unstructured":"Nishida H, Horio T, Suzuki Y et al (2008) Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides 29:599\u2013605","journal-title":"Peptides"},{"key":"4727_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1136\/hrt.2010.210948","volume":"97","author":"IT Klip","year":"2011","unstructured":"Klip IT, Voors AA, Anker SD et al (2011) Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 97:892\u2013898","journal-title":"Heart"},{"key":"4727_CR20","first-page":"135","volume":"14","author":"J Wang","year":"2017","unstructured":"Wang J, Tan GJ, Han LN et al (2017) Novelbiomarkers for cardiovascularriskprediction. J Geriatr Cardiol 14:135\u2013150","journal-title":"J Geriatr Cardiol"},{"key":"4727_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/2048872615612455","volume":"5","author":"P Bahrmann","year":"2016","unstructured":"Bahrmann P, Christ M, Hofner B et al (2016) Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department. Eur Heart J Acute Cardiovascular Care 5:568\u2013578","journal-title":"Eur Heart J Acute Cardiovascular Care"},{"key":"4727_CR22","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.2337\/dc07-2079","volume":"31","author":"S Hadjadj","year":"2008","unstructured":"Hadjadj S, Fumeron F, Roussel R et al (2008) Prognostic value of the insertion\/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies. Diabetes Care 31:1847\u20131852","journal-title":"Diabetes Care"},{"key":"4727_CR23","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s00125-016-4066-5","volume":"59","author":"B Gellen","year":"2016","unstructured":"Gellen B, Thorin-Trescases N, Sosner P et al (2016) ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. Diabetologia 59:2321\u20132330","journal-title":"Diabetologia"},{"key":"4727_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803\u2013869","journal-title":"Eur J Heart Fail"},{"key":"4727_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"issue":"1","key":"4727_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1\u201339","journal-title":"J Am Soc Echocardiogr"},{"key":"4727_CR27","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","volume":"56","author":"AJ Hayes","year":"2013","unstructured":"Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM (2013) UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia 56:1925\u20131933","journal-title":"Diabetologia"},{"key":"4727_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/0014-5793(94)80106-1","volume":"338","author":"Y Ichiki","year":"1994","unstructured":"Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T (1994) Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338:6\u201310","journal-title":"FEBS Lett"},{"key":"4727_CR29","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1006\/bbrc.1994.1827","volume":"201","author":"S Sugo","year":"1994","unstructured":"Sugo S, Minamino N, Kangawa K et al (1994) Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201:1160\u20131166","journal-title":"Biochem Biophys Res Commun"},{"key":"4727_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1006\/bbrc.1994.2241","volume":"203","author":"S Sugo","year":"1994","unstructured":"Sugo S, Minamino N, Shoji H et al (1994) Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 203:719\u2013726","journal-title":"Biochem Biophys Res Commun"},{"key":"4727_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jemt.10052","volume":"57","author":"K Kitamura","year":"2002","unstructured":"Kitamura K, Kangawa K, Eto T (2002) Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech 57:3\u201313","journal-title":"Microsc Res Tech"},{"key":"4727_CR32","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.bjp.0701034","volume":"120","author":"DG Parkes","year":"1997","unstructured":"Parkes DG, May CN (1997) Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 120:1179\u20131185","journal-title":"Br J Pharmacol"},{"issue":"Suppl","key":"4727_CR33","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1291\/hypres.26.S121","volume":"26","author":"T Nishikimi","year":"2003","unstructured":"Nishikimi T, Yoshihara F, Mori Y, Kangawa K, Matsuoka H (2003) Cardioprotective effect of adrenomedullin in heart failure. Hypertens Res 26(Suppl):S121\u2013S127","journal-title":"Hypertens Res"},{"key":"4727_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/00005344-200205000-00017","volume":"39","author":"N Nagaya","year":"2002","unstructured":"Nagaya N, Goto Y, Satoh T et al (2002) Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol 39:754\u2013760","journal-title":"J Cardiovasc Pharmacol"},{"key":"4727_CR35","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.2337\/dc08-2168","volume":"32","author":"C Maier","year":"2009","unstructured":"Maier C, Clodi M, Neuhold S et al (2009) Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes. Diabetes Care 32:1890\u20131895","journal-title":"Diabetes Care"},{"key":"4727_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1373\/clinchem.2010.157842","volume":"58","author":"PS Wild","year":"2012","unstructured":"Wild PS, Schnabel RB, Lubos E et al (2012) Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study. Clin Chem 58:226\u2013236","journal-title":"Clin Chem"},{"key":"4727_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/07853890.2013.874662","volume":"46","author":"A Funke-Kaiser","year":"2014","unstructured":"Funke-Kaiser A, Havulinna AS, Zeller T et al (2014) Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort. Ann Med 46:155\u2013162","journal-title":"Ann Med"},{"key":"4727_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cardfail.2014.12.007","volume":"21","author":"P Holmeger","year":"2015","unstructured":"Holmeger P, Morten S, Egstrup M et al (2015) The influence of diabetes mellitus on midregional proadrenomedullin concentrations and pronostic value in heart failure outpatients. J Card Fail 21:250\u2013257","journal-title":"J Card Fail"},{"key":"4727_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/jamacardio.2017.4987","volume":"3","author":"RA Boer De","year":"2018","unstructured":"De Boer RA, Nayor M, deFilippi CR et al (2018) Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction. JAMA Cardiol 3:215\u2013224","journal-title":"JAMA Cardiol"},{"key":"4727_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jama.2013.7588","volume":"310","author":"M Ledwidge","year":"2013","unstructured":"Ledwidge M, Gallagher J, Conlon C et al (2013) Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA 310:66\u201374","journal-title":"JAMA"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4727-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T23:03:44Z","timestamp":1568847824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4727-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4727-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"assertion":[{"value":"22 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Plasma MR-proADM measurement was performed by Thermo Fisher Scientific (Hennigsdorf, Germany), in anonymised tubes, by personnel blinded to characteristics and outcomes of participants. No other potential duality of interest relevant to this article was reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}